Medical Discounter: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Medical Discounter
Largest movements
- Current investments +€17,496
new in 2025: €17,496
- Cash -€11,775
no longer reported in 2025 (was €11,775)
mainly Current investments (-€17,496) and Trade debts (-€1,455)
- Receivables within one year -€1,962
down €1,962 (-30.1%), from €6,508 to €4,546
- Tangible fixed assets -€757
down €757 (-25.3%), from €2,994 to €2,237
- Profit (loss) carried forward +€5,193
up €5,193, from -€3,092 to €2,101
- Trade debts -€1,455
down €1,455 (-44.3%), from €3,284 to €1,829
- Tax, wage and social debts -€429
down €429 (-27.7%), from €1,549 to €1,120
- Other debts -€307
down €307 (-32.8%), from €936 to €629
- Gross operating margin +€12,324
up €12,324, from -€6,013 to €6,311
- Financial charges +€217
up €217 (+75.6%), from €287 to €504
- Financial income +€121
new in 2025: €121
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €21,277 | €24,279 | +€3,002 | +14.1% |
| Fixed assets | 21/28 | €2,994 | €2,237 | -€757 | -25.3% |
| Tangible fixed assets | 22/27 | €2,994 | €2,237 | -€757 | -25.3% |
| Plant, machinery and equipment | 23 | €2,994 | €2,237 | -€757 | -25.3% |
| Current assets | 29/58 | €18,283 | €22,042 | +€3,759 | +20.6% |
| Amounts receivable within one year | 40/41 | €6,508 | €4,546 | -€1,962 | -30.1% |
| Trade receivables | 40 | €6,508 | €4,546 | -€1,962 | -30.1% |
| Current investments | 50/53 | - | €17,496 | +€17,496 | |
| Cash at bank and in hand | 54/58 | €11,775 | - | -€11,775 | |
| Total equity and liabilities | 10/49 | €21,277 | €24,279 | +€3,002 | +14.1% |
| Equity | 10/15 | €15,508 | €20,701 | +€5,193 | +33.5% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€3,092 | €2,101 | +€5,193 | |
| Amounts payable | 17/49 | €5,769 | €3,578 | -€2,191 | -38.0% |
| Amounts payable within one year | 42/48 | €5,769 | €3,578 | -€2,191 | -38.0% |
| Trade debts | 44 | €3,284 | €1,829 | -€1,455 | -44.3% |
| Suppliers | 440/4 | €3,284 | €1,829 | -€1,455 | -44.3% |
| Taxes, remuneration and social security | 45 | €1,549 | €1,120 | -€429 | -27.7% |
| Taxes | 450/3 | €1,549 | €1,120 | -€429 | -27.7% |
| Other amounts payable | 47/48 | €936 | €629 | -€307 | -32.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €757 | €757 | = | 0.0% |
| Gross operating margin | 9900 | -€6,013 | €6,311 | +€12,324 | |
| Operating profit (loss) | 9901 | -€6,770 | €5,554 | +€12,324 | |
| Financial income | 75/76B | - | €121 | +€121 | |
| Recurring financial income | 75 | - | €121 | +€121 | |
| Financial charges | 65/66B | €287 | €504 | +€217 | +75.6% |
| Recurring financial charges | 65 | €287 | €504 | +€217 | +75.6% |
| Profit (loss) for the period before taxes | 9903 | -€7,057 | €5,171 | +€12,228 | |
| Income taxes | 67/77 | - | -€22 | -€22 | |
| Profit (loss) for the period | 9904 | -€7,057 | €5,193 | +€12,250 | |
| Profit (loss) for the period to be appropriated | 9905 | -€7,057 | €5,193 | +€12,250 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.